Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Corti, C. Antonarelli, G. Scotté, F. Spano, J. P. Barrière, J. Michot, J. M. André, F. Curigliano, G.

Seroconversion rate after vaccination against COVID-19 in patients with cancer - a systematic review

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ramli, N. S. Ismail, N. M. Zaini, N. Hayati, F. Jeffree, M. S. Rahim, S. S. S. A. Hassan, M. R.

Seroepidemiological Studies on Japanese Encephalitis: A Systematic Review

  • South-East Asia
  • All age groups
  • Japanese encephalitis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ge, C. Du, K. Luo, M. Shen, K. Zhou, Y. Guo, K. Liu, Y. Yin, C. Li, Y. Li, G. Chen, X.

Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Sakuraba, A. Luna, A. Micic, D.

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, D. Pan, Y. Wang, Y. Chen, X. Zhang, J. Zhang, Y. Ding, T. Yang, Z. Lu, T. Zheng, Y. Wei, J. Kong, W. Li, H. Yin, X. Yang, G. Zhang, G. Wang, X.

Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Auroux, Maxime Laurent, Benjamin Coste, Baptiste Massy, Emmanuel Mercier, Alexandre Durieu, Isabelle Confavreux, Cyrille B. Lega, Jean-Christophe Mainbourg, Sabine Coury, Fabienne

Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: a cohort study and a systematic review with meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bonkat, N. Fellendorf, F. T. Dalkner, N. Reininghaus, E. Z.

Severe mental disorders and vaccinations - a systematic review

  • Adolescents
  • Adults
  • Older adults
  • Pregnant women
  • Coverage
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ MarraMs, Alexandre R. M. D. Kobayashi, Takaaki Suzuki, Hiroyuki Alsuhaibani, Mohammed Tofaneto, Bruna Marques Bariani, Luigi Makowski Auler, Mariana de Amorim Salinas, Jorge L. Edmond, Michael B. Doll, Michelle Kutner, José Mauro Pinho, João Renato Rebello Rizzo, Luiz Vicente Miraglia, João Luiz Schweizer, Marin L.

Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Lin, Kan Huang, Huayao Fang, Shuangfang Zheng, Guanyi Fu, Kailong Liu, Nan Du, Houwei

Should patients with epilepsy be vaccinated against coronavirus disease 2019? A systematic review and meta-analysis

  • All age groups
  • Parents/caregivers
  • COVID-19
  • Coverage
  • Safety
  • Acceptance
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bass, J. R. Poland, G. A.

Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...